Mesenchymal stem cells (MSCs) have been investigated to treat liver diseases, but the efficiency of MSCs to treat chronic liver diseases is conflicting. 
| INTRODUCTION
Liver fibrosis is the end stage of most of liver diseases and is a serious health care problem worldwide. 1 In the damaged liver, hepatic stellate cells (HSCs) are activated and produce excessive extracellular matrix components (ECM). 2 Transforming growth factor (TGF)-β is a key mediator of hepatic fibrosis and triggers the activation of HSCs, induces ECM synthesis and increases apoptosis of hepatocytes. 3 Liver transplantation is still considered to be the most effective treatment for end-stage liver disease, but has several limitations.
Recent studies suggest that adipose derived stem cells (ADSCs)
show beneficial effects to improve liver fibrosis. 4 In addition, fibroblast growth factor (FGF) 21 improves lipid profiles and hepatic steatosis. 5 To enhance the therapeutic effects of ADSCs on liver fibrosis, we established FGF21-secreting ADSCs (FGF21_ADSCs) and investigated their effects on thioacetamide (TAA)-induced liver fibrosis in mice.
| MATERIALS AND METHODS

| Animal experiments
Eight-week-old C57BL/6 male mice were obtained from the Orient
Bio Inc (Seongnam, Gyeonggi, Korea). TAA (200 mg/kg; Sigma, St. Louis, MO, USA) was intraperitoneally injected three times a week for 8 weeks. Mice were intravenously injected with either 
| Preparation of conditioned medium (CM)
Control or Igk_FGF21 plasmids were transfected into 5 × 10 5
ADSCs (R7788-110; Invitrogen, Carlsbad, CA, USA). After 1 day, the medium was replaced with 1% FBS-DMEM. After 24 hours, medium was filtered and mixed with an equal volume of 1% FBS-DMEM.
| Histological analysis
Hematoxylin and eosin (H&E) or Masson's trichrome staining was carried out using paraffin-embedded sections. For immunofluorescence staining, liver sections were blocked and incubated with primary antibodies and fluorescence-conjugated secondary antibodies.
DAPI was used for nuclear counterstain. Antibodies used for staining are listed in Table S1 .
| Western blot analysis
Total proteins were extracted, separated by 8%-12% SDS-PAGE and transferred to membranes. After blocking, membranes were incubated with primary antibodies and horseradish peroxidase-conjugated secondary antibodies. Signals were detected and quantified with ChemiDoc XRS+ system using Image Lab software (Bio-Rad, Hercules, CA, USA) with the Immobilon Western Chemiluminescent HRP Substrate (Millipore). Antibodies used for western blotting are listed in Table S1 .
| Secretome analysis
Proteins were digested and analysed by Q-Exactive orbitrap hybrid mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA)
with Easy-Nlc 1000 system as described previously. 
| Statistical analysis
All data are expressed as mean ± SEM of at least three independent experiments. All statistics were performed using one-way ANOVA (SPSS 19.0 statistical software, IBM, Armonk, NY, USA). P-values less than 0.05 were considered statistically significant.
| RESULTS
| Effect of FGF21_ADSCs transplantation on amelioration of liver fibrosis
We constructed the Igκ_FGF21 plasmid to facilitate the secretion of 
| Effect of FGF21_ADSCs conditioned media on TGF-β1-induced activation of HSCs
We determined whether factors secreted from FGF21_ADSCs affect HSC activation in LX-2 cells using CM from Empty_ADSCs or (Figure 2A,B) . These results suggest that soluble factors from FGF21_ADSCs, other than FGF21, might contribute to the inhibitory effect on HSC activation.
| Regulation of JNK and Smad2/3 signalling by
FGF21_ADSCs
JNK and NF-κB signalling pathways are involved in the expression of α-SMA and collagen. 7, 8 Protein levels of p-JNK and NF-κB were increased in LX-2 cells activated by TGF-β1, and this increase was inhibited by 
| Secretome analysis of FGF21_ADSCs CM
Secretome analysis by mass spectrometry identified 365 proteins in FGF21_ADSCs CM, of which 33 showed a significant increase and 39 showed a significant decrease as compared with Empty_ADSCs | 5167 CM (data not shown). Among the proteins that were increased over 2-fold ( Figure S4 ), we chose lactotransferrin (LTF) and α-lactoalbumin (α-LA) for further analysis, because they inhibit liver fibrosis. 10, 11 Western blot analysis showed that LTF and α-LA secretion was significantly increased in FGF21_ADSCs CM compared with Empty_ADSCs CM ( Figure 2G ). When we treated LX-2 cells with LTF or α-LA in the presence of TGF-β1, the TGF-β1-induced expression of α-SMA and Col1a1 was inhibited ( Figure 2H,I ). These results indicate that secretory factors such as α-LA and LTF, which are altered in FGF21_ADSCs, can improve hepatic fibrosis compared to Empty_ADSCs. 12 Collagen, TIMP-1 and α-SMA are TGF-β target genes, and are expressed via the JNK and Smad2/3 signalling pathway. 13 Our results showed that ADSCs transplantation reduced TAAinduced JNK and Smad2/3 activation in vivo, with more potent inhibition by transplantation of FGF21_ADSCs than Empty_ADSCs.
| DISCUSSION
The therapeutic effect of MSC therapy is due to a variety of biologically active factors produced by them. 14 Our study showed that CM from FGF21_ADSCs significantly inhibited TGF-β-induced expression of fibrogenic factors compared with CM from Empty_ADSCs. Interestingly, when LX-2 cells, a human HSC line, were incubated with the same amount of FGF21 as found in the CM of FGF21_ADSCs, there was almost no effect on the inhibition of JNK and Smas2/3 activation, suggesting that soluble factors other than FGF21 might contribute to this stronger inhibitory effect. Among the secreted proteins upregulated in the FGF21_ADSCs CM, we noted that α-LA and LTF might be involved in the inhibition of fibrogenic activity. α-LA and LTF have a liver protective and anti-fibrotic effect, respectively. 10, 11 We confirmed that α-LA or LTF treatment inhibited TGF-β-induced α-SMA and Col1a1 expression in LX-2 cells.
Therefore, α-LA and LTF secreted by FGF21_ADSCs might contribute in part to the potent inhibitory effect of these cells on liver fibrosis in our model.
